Super-TDU

Catalog No.S8554 Batch:S855401

Technical Data

Formula	C₂₃₇H₃₇₀N₆₆O₆₉S
Molecular Weight	5279.94	CAS No.	1599441-71-0
Solubility (25°C)*	In vitro	Water	100 mg/mL (18.93 mM)


* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. * Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description

Super-TDU is an inhibitory peptide targeting YAP-TEADs interaction.

Targets

YAP/TEAD interaction ^[1]

In vitro

Super-TDU reduced endogenous interaction between YAP and TEADs. It inhibits cell viability and colony formation of GC cell lines MGC-803, BGC-823, and HGC27, but not MKN-45. Moreover, the Super-TDU downregulated expression of YAP-TEADs target genes CTGF, CYR61, and CDX2. Super-TDU significantly inhibited growth of HeLa, MGC-803, HCT116, A549, and MCF-7 cells, but only marginally inhibited growth of Jurkat and Raji cells, indicating a selectivity of the Super-TDU in inhibiting tumor cell growth. Super-TDU may specifically target tumor cells with an elevated YAP/VGLL4 ratio^[1].

In vivo

Super-TDU has the potential in treating gastric cancer by directly targeting YAP-TEADs, and importantly, unlike the conventional drug compound 5-FU, its antitumor activity tends to be specific toward tumors with an elevated ratio of YAP to VGLL4^[1].

Protocol (from reference)

Cell Assay:^{^[2]}	Cell lines HCT116 and SW480 cells Concentrations 0-320 ng/ml Incubation Time 72 h Method Cells are transfected with the indicated plasmids. An ATP-based cell viability assay is used for detecting cell proliferation. The ATP content is measured. Briefly, 100 μl of assay reagent is added to the wells, and mixed for 2 min at room temperature. After 10 min, intracellular ATP content is measured using a multilabel luminescence counter. Cell viability is calculated.
Animal Study:^{^[1]}	Animal Models BALB/cA nu/nu mice Dosages 50 or 500 μg/kg Administration tail vein injection

Cell Assay:^{^[2]}

Cell lines
HCT116 and SW480 cells
Concentrations
0-320 ng/ml
Incubation Time
72 h
Method
Cells are transfected with the indicated plasmids. An ATP-based cell viability assay is used for detecting cell proliferation. The ATP content is measured. Briefly, 100 μl of assay reagent is added to the wells, and mixed for 2 min at room temperature. After 10 min, intracellular ATP content is measured using a multilabel luminescence counter. Cell viability is calculated.

Animal Study:^{^[1]}

Animal Models
BALB/cA nu/nu mice
Dosages
50 or 500 μg/kg
Administration
tail vein injection

References

Selleck's Super-TDU has been cited by 12 publications

Involvement of lysophosphatidic acid-LPA1-YAP signaling in healthy and pathological FAPs migration [ Matrix Biol, 2024, S0945-053X(24)00107-0]	PubMed: 39153517
YAP and β-catenin cooperate to drive H. pylori-induced gastric tumorigenesis [ Gut Microbes, 2023, 15(1):2192501]	PubMed: 36959122
PDK4 rescues high-glucose-induced senescent fibroblasts and promotes diabetic wound healing through enhancing glycolysis and regulating YAP and JNK pathway [ Cell Death Discov, 2023, 9(1):424]	PubMed: 38001078
CCN1 interacts with integrins to regulate intestinal stem cell proliferation and differentiation [ Nat Commun, 2022, 13(1):3117]	PubMed: 35660741
Senescent hepatic stellate cells promote liver regeneration through IL-6 and ligands of CXCR2 [ JCI Insight, 2022, 7(14)e158207]	PubMed: 35708907
Starvation mediates pancreatic cancer cell sensitivity to ferroptosis via ERK1/2, JNK and changes in the cell mesenchymal state [ Int J Mol Med, 2022, 49(6)84]	PubMed: 35514314
Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers [ Exp Dermatol, 2022, 31(10):1477-1499]	PubMed: 35913427
ACTN1 supports tumor growth by inhibiting Hippo signaling in hepatocellular carcinoma [ J Exp Clin Cancer Res, 2021, 40(1):23]	PubMed: 33413564
Targeting Mechanosensitive Piezo1 Alleviated Renal Fibrosis Through p38MAPK-YAP Pathway [ Front Cell Dev Biol, 2021, 9:741060]	PubMed: 34805150
Targeting Mechanosensitive Piezo1 Alleviated Renal Fibrosis Through p38MAPK-YAP Pathway [ Front Cell Dev Biol, 2021, 9:741060]	PubMed: 34805150

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.